Mir-338-3p Increases the Sensitivity to Oxaliplatin via Reversing EpithelialmesenchymalTransition in Hepatocellular Carcinoma Cells
This study implies that the resistance of SMMC-7721/OXA cells to OXA is likely related to the acquisition of the EMT phenotype. The up-regulating miR-338-3p could be a new treatment method for over-coming OXA resistance in hepatocellular carcinoma.
Authors
- Chuan Huang (ORCID: https://orcid.org/0000-0002-0290-5597)
- Wen Yan (ORCID: https://orcid.org/0000-0002-9189-0840)
- Zhenguang Huang
- Jun Luo
- Ruiqiang Zhao
- Meiyi Wu
- Kaining Cai
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Recent Patents on Anti-Cancer Drug Discovery
- Published
- 2026-01-12
- DOI
- https://doi.org/10.2174/0115748928408751251113182005
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00